2019 American Transplant Congress
Donor – Recipient Size Mismatch Has No Impact on Outcomes after Deceased Donor Whole Liver Transplantation: A Single Center Analysis
*Purpose: Assessment of donor size by demographic variables is an important part of deceased donor evaluation prior to liver transplantation (LT). Lack of liver volumetric…2019 American Transplant Congress
De Novo Hepatitis B Virus Infection after Pediatric Living Donor Liver Transplantation: Risk Factors, Recognition and Prevention Strategies
Renji Hospital, Shanghai, China
*Purpose: To evaluate the risk factors of De novo Hepatitis B, especially the Hepatitis B serotype of both doners and recipients in pediatric living donor…2019 American Transplant Congress
Utility of Protocol Ultrasound Surveillance in Liver Transplantation
*Purpose: The purpose of this study was to assess the utilization of doppler ultrasound in the immediate post-operative period of liver transplant patients. We hypothesized…2019 American Transplant Congress
Nivolumab-Induced Rejection of a Liver Allograft: PD-1 Inhibition Thwarts Liver Allograft Resistance to Humoral Rejection
Surgery, USC Keck School of Medicine, Los Angeles, CA
*Purpose: Checkpoint inhibitor therapy with Programmed cell death protein (PD-1) inhibitors has recently been FDA approved for the treatment of several malignancies. However, it has…2019 American Transplant Congress
Notch1 Signaling Protects Liver Grafts from Ischemia Reperfusion Injury: From Mouse to Human
Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: The clinical relevance and tissue-specific role of Notch1 activation, a highly conserved transmembrane receptor involved in cell fate decision, proliferation and regeneration, in orthotopic…2019 American Transplant Congress
Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study
*Purpose: Orthotopic liver transplant (OLTx) is the most common method to treat unresectable hepatoblastoma (HB) in children. There is limited data focusing on the outcomes…2019 American Transplant Congress
Prevention of Graft Ischemia-Reperfusion Injury in Ischemia-Free Liver Transplantation
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Graft ischemia-reperfusion injury (IRI) is an inevitable event in organ transplantation, which often leads to a number of complications and even patient deaths. We…2019 American Transplant Congress
Liver Transplant Candidate Attitudes towards Organs from Increased Risk Donors: A Single Center Survey
University Health Network, Toronto, ON, Canada
*Purpose: Increased Risk Donors (IRDs) are a significant proportion of the deceased organ donor pool but may be declined by patients on the liver transplant…2019 American Transplant Congress
Discard Patterns in Donors with Non Alcoholic Fatty Liver Disease
*Purpose: Obesity and nonalcoholic fatty liver disease (NAFLD) are major health issues affecting 20-50% of the US adult population and are increasingly prevalent in potential…2019 American Transplant Congress
A Randomized Controlled Clinical Trial of Thymoglobulin® and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection after Liver Transplantation: A Multicenter Study
*Purpose: Thymoglobulin® (r-ATG) has been used as induction therapy in liver transplantation (LT). No prospective, randomized, controlled, trial (RCT) has been performed to evaluate effect…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 180
- Next Page »